Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NYSE:OPK)

Delayed Data
As of Feb 05
 -0.18 / -2.13%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary technologies with a focus to provide unmet medical needs through a range of develops solutions to diagnose, treat and prevent various conditions, including molecular diagnostics, point-of-care tests and proprietary pharmaceuticals and vaccines. It operates its business through two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment consists of pharmaceutical research and development, which is focused on the research and development of pharmaceutical products and vaccines. The Diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. OPKO Health was founded in October 1991 and is headquartered in Miami, FL.

Contact Information

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami Florida 33137
P:(305) 575-4100
Investor Relations:



Mutual fund holders9.82%
Individual stakeholders41.83%
Other institutional13.57%

Top Executives

Phillip FrostChairman & Chief Executive Officer
Adam E. LogalChief Financial Officer, Treasurer, CAO & SVP
Jane H. HsiaoVice Chairman & Chief Technology Officer
Stephen A. StrugnellSenior Director-Scientific Affairs
Steven D. RubinDirector & Executive Vice President-Administration